Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

HCA Lung Biological Network, the Deutsche COVID-19 Omics Initiative (DeCOI)

Research output: Contribution to journalArticlepeer-review

223 Scopus citations

Abstract

Bernardes et al. explore COVID-19 disease trajectories by performing longitudinal multi-omics analyses in peripheral blood samples from hospitalized patients. The analyses identify increased numbers of plasmablasts, interferon-activated megakaryocytes, and erythroid cells as hallmarks of severe disease and define molecular signatures linked to a fatal COVID-19 disease outcome.

Original languageEnglish (US)
Pages (from-to)1296-1314.e9
JournalImmunity
Volume53
Issue number6
DOIs
StatePublished - Dec 15 2020

Keywords

  • COVID-19
  • RNA-seq
  • acute respiratory distress
  • blood
  • disease trajectory
  • immune response
  • infectious disease
  • methylation
  • scRNA-seq
  • virus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19'. Together they form a unique fingerprint.

Cite this